Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
James Chesko
Advertisement
James Chesko is a senior scientist at the Infections Disease Research Institute
Articles by James Chesko
Advertisement
Latest Updated Articles
Advertisement
Advertisement